Business Description
UnitedHealth Group Inc
NAICS : 524114
SIC : 6324
9900 Bren Road East, UnitedHealth Group Center, Minnetonka, MN, USA, 55343
Compare
Compare
Traded in other countries / regions
UNH.Austria
•
UNHH34.Brazil
•
UNH.Canada
•
UNH.Chile
•
UNH.Germany
•
UNH.Mexico
•
UNH.Peru
•
UNH.Switzerland
•
0R0O.UK
•
UNH.USA
Description
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.54 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.71 | |||||
| Debt-to-EBITDA | 1.8 | |||||
| Interest Coverage | 13.32 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 4.09 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.3 | |||||
| 3-Year EBITDA Growth Rate | 12.1 | |||||
| 3-Year EPS without NRI Growth Rate | 14 | |||||
| 3-Year FCF Growth Rate | 14.4 | |||||
| 3-Year Book Growth Rate | 12.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 12.92 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 8.96 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.62 | |||||
| 9-Day RSI | 56.54 | |||||
| 14-Day RSI | 57.67 | |||||
| 6-1 Month Momentum % | 4.57 | |||||
| 12-1 Month Momentum % | 22.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.77 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.32 | |||||
| Days Sales Outstanding | 19.3 | |||||
| Days Payable | 80.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.12 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 17.5 | |||||
| Forward Dividend Yield % | 1.23 | |||||
| 5-Year Yield-on-Cost % | 2.65 | |||||
| 3-Year Average Share Buyback Ratio | 0.7 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 23.51 | |||||
| Operating Margin % | 7.67 | |||||
| Net Margin % | 5.99 | |||||
| ROE % | 25.59 | |||||
| ROA % | 8.4 | |||||
| ROIC % | 10.05 | |||||
| ROC (Joel Greenblatt) % | 281.26 | |||||
| ROCE % | 18.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28 | |||||
| Forward PE Ratio | 24.6 | |||||
| PE Ratio without NRI | 28 | |||||
| Shiller PE Ratio | 42.77 | |||||
| Price-to-Owner-Earnings | 25.22 | |||||
| PEG Ratio | 2.12 | |||||
| PS Ratio | 1.69 | |||||
| PB Ratio | 6.89 | |||||
| Price-to-Free-Cash-Flow | 24.97 | |||||
| Price-to-Operating-Cash-Flow | 22.24 | |||||
| EV-to-EBIT | 20.72 | |||||
| EV-to-Forward-EBIT | 18.87 | |||||
| EV-to-EBITDA | 18.43 | |||||
| EV-to-Forward-EBITDA | 16.86 | |||||
| EV-to-Revenue | 1.73 | |||||
| EV-to-Forward-Revenue | 1.63 | |||||
| EV-to-FCF | 25.62 | |||||
| Price-to-Projected-FCF | 1.84 | |||||
| Price-to-DCF (Earnings Based) | 0.99 | |||||
| Price-to-DCF (FCF Based) | 0.83 | |||||
| Price-to-Median-PS-Value | 1.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.22 | |||||
| Earnings Yield (Greenblatt) % | 4.82 | |||||
| Forward Rate of Return (Yacktman) % | 15.83 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:UNH
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 304,583 | ||
| EPS (TTM) ($) | 19.15 | ||
| Beta | 0.81 | ||
| Volatility % | 25.6 | ||
| 14-Day RSI | 57.67 | ||
| 14-Day ATR ($) | 11.343901 | ||
| 20-Day SMA ($) | 527.0375 | ||
| 12-1 Month Momentum % | 22.87 | ||
| 52-Week Range ($) | 383.12 - 553.29 | ||
| Shares Outstanding (Mil) | 935.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
UnitedHealth Group Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||